Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. A combination of strong organic growth and a progressive acquisition-led strategy has seen the company assemble an impressive portfolio of over 400 products to date.
Specialising in the development, manufacture and marketing of diagnostic test kits, Trinity Biotech’s continued success is based on the fact that as a company it consistently achieves standards of excellence in the quality of all it does.
The test kits manufactured by Trinity Biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. The company is also a significant provider of raw materials to the life sciences industry.
Quoted on the NASDAQ exchange, and with facilities spanning Europe and America, Trinity Biotech sells its products in more than 75 countries. It reaches this worldwide market by combining the skills of its own sales force with a network of international distributors and strategic partners.
Trinity Biotech has manufacturing facilities in:
Bray, Ireland - Rapids, Infectious Disease
Carlsbad, USA – Infectious Disease – Western Blot, Point-of-care development
Acton, USA – Raw materials for supply to the research and diagnostic industries
Jamestown, USA – Infectious Disease – Enzyme Immunoassay (EIA)
Kansas City, USA –Diabetes Diagnostics based on Boronate Affinity HPLC
自從1992年建立以來,Trinity Biotech 公司繼續(xù)積極從事于診斷行業(yè),目標(biāo)是成為一個*者。強(qiáng)有機(jī)的增長和不斷進(jìn)步的戰(zhàn)略模式見證了公司的榮譽(yù)。 迄今為止Trinity Biotech 公司組裝過的組合已經(jīng)超過了400種。
專業(yè)發(fā)展于診斷器材的銷售和制造, 三一生物技術(shù)的持續(xù)成功依賴于公司始終如一的質(zhì)量標(biāo)準(zhǔn)。
Trinity Biotech公司生產(chǎn)測試套件主要用于
臨床實(shí)驗(yàn)室和臨時診斷市場細(xì)分的探測傳染病、性傳播疾病、自身免疫和血紅蛋白疾患、探測、監(jiān)視和控制糖尿病方面。
公司也是生命科學(xué)行業(yè)理重要的原材料供應(yīng)商。
從納斯達(dá)克交易所獲悉,三一生物技術(shù)產(chǎn)品已經(jīng)橫跨歐洲和美國熱銷于世界上75個國家。通過自身的技能和網(wǎng)絡(luò)銷售能力已經(jīng)與世界各地的分銷商形成了戰(zhàn)略伙伴關(guān)系。
TRINITY 公司是的臨床診斷試劑及臨床免疫類儀器生產(chǎn)供應(yīng)商,*納斯達(dá)克上市的醫(yī)藥企業(yè)。公司商業(yè)總部位于愛爾蘭都柏林,在紐約Jamston, California,,英國warehouse, 德國,加拿大,瑞典均設(shè)有生產(chǎn)基地。自1992年成立以來,已在收購十多家醫(yī)藥生物公司。其產(chǎn)品范圍包括自身免疫性疾病的診斷,激素類診斷試劑,藥物監(jiān)測,性傳播疾病和傳染病血清學(xué)診斷,及臨床血液部門檢測(Sigma),臨床凝血檢測(Biopool)。
Trinity Biotech的制造設(shè)備基地如下:
布雷,愛爾蘭-急流,傳染病
卡爾斯巴德,美國-傳染病,免疫印跡,現(xiàn)階段的發(fā)展
阿克頓,美國-原材料供應(yīng)的研究和診斷行業(yè)
詹姆斯敦,美國-傳染病——酶免疫測定(EIA)
堪薩斯城,美國--基于液相色譜Boronate親和力糖尿病診斷
PRODUCTBRANDCODEKIT
Lp(a) – Additional automation componentsMacra®AT910096 tests
Macra® Lp(a)Macra®233910096 tests